2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …
Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization …
M Glikson, JC Nielsen, MB Kronborg, Y Michowitz… - EP …, 2022 - academic.oup.com
for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines …
detailed information, the user should always access to the full text version of the guidelines …
Diretriz brasileira de insuficiência cardíaca crônica e aguda
LEP Rohde, MW Montera, EA Bocchi… - Arq. bras …, 2018 - pesquisa.bvsalud.org
A organização de uma diretriz clínica é tarefa complexa, que necessariamente deve
envolver planejamento prévio, coordenação apropriada, revisão aprofundada da literatura …
envolver planejamento prévio, coordenação apropriada, revisão aprofundada da literatura …
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European …
Authors/Task Force Members, M Brignole… - European heart …, 2013 - academic.oup.com
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …
for personal and educational use only. No commercial use is authorized. No part of the ESC …
Effectiveness of cardiac resynchronization therapy by QRS morphology in the multicenter automatic defibrillator implantation trial–cardiac resynchronization therapy …
W Zareba, H Klein, I Cygankiewicz, WJ Hall, S McNitt… - Circulation, 2011 - Am Heart Assoc
Background—This study aimed to determine whether QRS morphology identifies patients
who benefit from cardiac resynchronization therapy with a defibrillator (CRT-D) and whether …
who benefit from cardiac resynchronization therapy with a defibrillator (CRT-D) and whether …
2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and …
Authors/Task Force Members, K Dickstein… - Europace, 2010 - academic.oup.com
HFA Heart Failure Association Hosp hospitalization ICD implantable cardioverter
defibrillator LBBB left bundle branch block LV left ventricular LVAD left ventricular assist …
defibrillator LBBB left bundle branch block LV left ventricular LVAD left ventricular assist …
[PDF][PDF] Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda
CCD De Insuficiência, C Colaboradores… - Arq Bras Cardiol, 2018 - SciELO Brasil
A organização de uma diretriz clínica é tarefa complexa, que necessariamente deve
envolver planejamento prévio, coordenação apropriada, revisão aprofundada da literatura …
envolver planejamento prévio, coordenação apropriada, revisão aprofundada da literatura …
In search of new therapeutic targets and strategies for heart failure: recent advances in basic science
AM Shah, DL Mann - The Lancet, 2011 - thelancet.com
Chronic heart failure continues to impose a substantial health-care burden, despite recent
treatment advances. The key pathophysiological process that ultimately leads to chronic …
treatment advances. The key pathophysiological process that ultimately leads to chronic …
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management: A …
Task Force Chairs, JC Daubert, L Saxon… - Europace, 2012 - academic.oup.com
Background Cardiac resynchronization therapy (CRT) is one of the most successful heart
failure therapies to emerge in the last 25 years and is applicable to∼ 25–30% of patients …
failure therapies to emerge in the last 25 years and is applicable to∼ 25–30% of patients …
2022 ACC/AHA/HFSA guideline for the management of heart failure
ABSTRACT Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …